Concepedia

Tingyi Cao

TC

Statistics

Publications

15

Citations

1.6K

H-Index

12

Active since

2015

Affiliations

Harvard University(Current)

Massachusetts General Hospital

Brigham and Women's Hospital

University of California, San Francisco

Boston University

Tingyi Cao is an author at Harvard University specializing in medicine, immunology, and vascular biology.

ORCID

Top concepts

Publications per year

2015–2024

15

Publications

15

Development of a Definition of Postacute Sequelae of SARS-CoV-2 Infection

Tanayott Thaweethai, Sarah E. Jolley, Elizabeth W. Karlson et al. · JAMA · 2023 · 792 citations · Full text

RIPK3 deficiency or catalytically inactive RIPK1 provides greater benefit than MLKL deficiency in mouse models of inflammation and tissue injury

Kim Newton, Debra L. Dugger, Allie Maltzman et al. · Cell Death and Differentiation · 2016 · 433 citations · Full text

Artificial intelligence-based screening for diabetic retinopathy at community hospital

Jie He, Tingyi Cao, Feiping Xu et al. · Eye · 2019 · 74 citations · Full text

, , +6

2024 Update of the RECOVER-Adult Long COVID Research Index

Linda N. Geng, Kristine M. Erlandson, Mady Hornig et al. · JAMA · 2024 · 48 citations · Full text

HMGB1 may act via RAGE to promote angiogenesis in the later phase after intracerebral hemorrhage

Chunyan Lei, S. Zhang, Tingyi Cao et al. · Neuroscience · 2015 · 47 citations

, , +11

1–5 of 15